FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Fund ProfileGlobal X - Genomics & Biotechnology ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
GNOM
Global X - Genomics & Biotechnology ETF ETF AnalysisComprehensive ETF analysis for Global X - Genomics & Biotechnology ETF (GNOM) including NAV, expense ratio, dividend yield, sector breakdown, and holdings data.ETF AnalysisGNOM
GNOM
Global X - Genomics & Biotechnology ETF
  • Fund Overview
  • Fund Data
  • Peer Comparison
  • Ownership & News
GNOM
  1. Home
  2. Screener
  3. Global X - Genomics & Biotechnology ETFGNOMETF
Global X - Genomics & Biotechnology ETF Logo

Global X - Genomics & Biotechnology ETF

ETF
🇺🇸GNOM•NASDAQ•Equity

Your view on GNOM

Global X - Genomics & Biotechnology ETF Logo

Global X - Genomics & Biotechnology ETF

ETFGlobal X
🇺🇸GNOM•NASDAQ•Equity
AUM (USD)$108.25M
Expense Ratio0.5%
Yield (TTM)1.10%
Holdings50

Sentiment

—

AUM (USD)

$108.25M

Expense Ratio

0.5%

Yield (TTM)

1.10%

Holdings

50

Sentiment

—
Fund Overview

Overview

What the fund invests in, who runs it, and what it costs.

Global X - Genomics & Biotechnology ETF (GNOM) is an Equity fund from Global X, listed since 2019, with $108.3M in assets under management, a 0.50% expense ratio and a NAV of $65.03 USD.

Overview for Global X - Genomics & Biotechnology ETF

Fund Type
ETF
Fund Issuer
Global X
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
April 5, 2019
Domicile
US
Website
globalxetfs.com/funds/GNOM
Fund Type
ETF
Fund Issuer
Global X
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
April 5, 2019
Domicile
US
Website
globalxetfs.com/funds/GNOM
Fund Type
ETF
Fund Issuer
Global X
Asset Class
Equity
Sector
Financial Services
Industry
Asset Management - Global
Inception Date
April 5, 2019
Domicile
US
Website
globalxetfs.com/funds/GNOM

About this fund

The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index.

Fund Data

Price Chart

Market price history and trading volume.

Key Facts

Cost, yield, size, and the fund's reference data.

Equity

Expense Ratio

0.5%

Yield (TTM)

1.10%

AUM

$108.25M

Fund Details

NAV$65.03 USD
Holdings50
Average Volume32.8K
Inception DateApril 5, 2019
Asset ClassEquity
Fund IssuerGlobal X
DomicileUS
ISINUS37960A2143
CUSIP37960A214
NAV CurrencyUSD

Expense Ratio

0.5%

Dividend Yield (TTM)

1.10%

Assets Under Management

$108.25M

NAV

$65.03 USD

Holdings

50

Average Volume

32.8K

Inception Date

April 5, 2019

Asset Class

Equity

Fund Issuer

Global X

Domicile

US

ISIN

US37960A2143

CUSIP

37960A214

NAV Currency

USD

Expense Ratio

0.5%

Dividend Yield (TTM)

1.10%

Assets Under Management

$108.25M

NAV

$65.03 USD

Holdings

50

Average Volume

32.8K

Inception Date

April 5, 2019

Asset Class

Equity

Fund Issuer

Global X

Domicile

US

ISIN

US37960A2143

CUSIP

37960A214

NAV Currency

USD

Distributions · last 12 months

Semi-Annual · 2 payments

Ex-datePaidAmount
Jun 29, 2026Jul 7, 2026$0.0579
Dec 30, 2025Jan 7, 2026$0.5912
Total, 12 months$0.65 a share

Dividend yield (TTM) 1.10% = $0.65 paid per share in the 12 months to Nov 20, 2026 ÷ the $59.23 price. Past distributions; future payments can differ.

Data last updated: Nov 14, 2026, 08:12 AM

Sectors

How the fund's assets are split across sectors.

2 sectors
  • 1Healthcare
    99.7%
  • 2Technology
    0.3%

Top sector

Healthcare

Top weight

99.7%

Top 3 weight

100.0%

Holdings

The securities the fund owns, by weight.

55 positions
1PRAXPRAXIS PRECISION MEDICINES I
5.22%
2MRNAMODERNA INC
4.74%
3BMRNBIOMARIN PHARMACEUTICAL INC
4.64%
4VRTXVERTEX PHARMACEUTICALS INC
4.62%
5TECHBIO-TECHNE CORP
4.55%
6QGENQIAGEN N.V.
4.51%
7BNTXBIONTECH SE-ADR
4.42%
8GHGUARDANT HEALTH INC
3.78%
9ARWRARROWHEAD PHARMACEUTICALS IN
3.61%
10NTRANATERA INC
3.42%
11CRSPCRISPR THERAPEUTICS AG
3.31%
12ILMNILLUMINA INC
3.26%
13CDNACAREDX INC
3.20%
14TXG10X GENOMICS INC-CLASS A
3.16%
151548.HKGENSCRIPT BIOTECH CORP
3.10%

Concentration

Total Holdings55
Top 10 Weight43.51%
Top HoldingPRAX
Top Weight5.22%
1PRAXPRAXIS PRECISION MEDICINES I
5.22%
2MRNAMODERNA INC
4.74%
3BMRNBIOMARIN PHARMACEUTICAL INC
4.64%
4VRTXVERTEX PHARMACEUTICALS INC
4.62%
5TECHBIO-TECHNE CORP
4.55%
6QGENQIAGEN N.V.
4.51%
7BNTXBIONTECH SE-ADR
4.42%
8GHGUARDANT HEALTH INC
3.78%
9ARWRARROWHEAD PHARMACEUTICALS IN
3.61%
10NTRANATERA INC
3.42%
11CRSPCRISPR THERAPEUTICS AG
3.31%
12ILMNILLUMINA INC
3.26%
13CDNACAREDX INC
3.20%
14TXG10X GENOMICS INC-CLASS A
3.16%
151548.HKGENSCRIPT BIOTECH CORP
3.10%

Total Holdings

55

Top 10 Weight

43.51%

Top Holding

PRAX

Top Weight

5.22%

1PRAXPRAXIS PRECISION MEDICINES I
5.22%$5.36M
2MRNAMODERNA INC
4.74%$4.87M
3BMRNBIOMARIN PHARMACEUTICAL INC
4.64%$4.77M
4VRTXVERTEX PHARMACEUTICALS INC
4.62%$4.74M
5TECHBIO-TECHNE CORP
4.55%$4.67M
6QGENQIAGEN N.V.
4.51%$4.62M
7BNTXBIONTECH SE-ADR
4.42%$4.54M
8GHGUARDANT HEALTH INC
3.78%$3.88M
9ARWRARROWHEAD PHARMACEUTICALS IN
3.61%$3.70M
10NTRANATERA INC
3.42%$3.51M
11CRSPCRISPR THERAPEUTICS AG
3.31%$3.40M
12ILMNILLUMINA INC
3.26%$3.34M
13CDNACAREDX INC
3.20%$3.28M
14TXG10X GENOMICS INC-CLASS A
3.16%$3.25M
151548.HKGENSCRIPT BIOTECH CORP
3.10%$3.18M

Total Holdings

55

Top 10 Weight

43.51%

Top Holding

PRAX

Top Weight

5.22%

Peer Comparison

Comparables

Funds similar to this one.

Side by side on what an ETF is compared on20 funds
FundAsset classExpense ratioAssetsHoldings
GNOMGlobal X - Genomics & Biotechnology ETFThis fundEquity0.50%$108M50

Comparable funds

  • BOATSonicShares Global Shipping ETFEquity0.69%$120M53
  • CSPFCohen & Steers Preferred and Income Opportunities Active ETFFixed Income0.59%$419M218
  • DEMZDemocratic Large Cap Core ETFEquity0.45%$69M42
  • DVYAiShares AsiaPacific Dividend ETFEquity0.49%$68M51
  • HTECROBO Global Healthcare Technology and Innovation ETFEquity0.80%$110M61
  • HYDRGlobal X - Hydrogen ETFEquity0.50%$69M25
  • IBIFiShares iBonds Oct 2029 Term TIPS ETFFixed Income0.10%$150M6
  • KSTRKraneShares SSE STAR Market 50 Index ETFEquity0.89%$274M53

More Global X ETFs

  • ALTYGlobal X - Alternative Income ETFEquity0.50%$45M20
  • AQWAGlobal X - Clean Water ETFEquity0.50%$21M40
  • ARGTGlobal X - MSCI Argentina ETFEquity0.59%$559M25
  • ASEAGlobal X - FTSE Southeast Asia ETFEquity0.65%$91M40
  • AUAUGlobal X - Gold Miners ETFEquity0.35%$6M115
  • AUSFGlobal X - Adaptive U.S. Factor ETFEquity0.27%$873M194
  • BANK.AXGlobal X - Australian Bank Credit ETFFixed Income0.25%$192M0
  • BITSGlobal X - Blockchain & Bitcoin Strategy ETFEquity0.65%$21M3
  • BKCC.TOGlobal X Equal Weight Canadian Bank Covered Call ETFEquity0.46%$381M0
  • BKCHGlobal X - Blockchain ETFEquity0.50%$169M33
  • BKCL.TOGlobal X Enhanced Equal Weight Canadian Banks Covered Call ETFEquity1.51%$195M0
  • BOTZGlobal X - Robotics & Artificial Intelligence ETFEquity0.68%$2.9B81
Ownership & News

Fund Holders

Institutions that own shares of this fund.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for this company. Press releases and market coverage, newest first.

News

Latest Market News

News

Latest Market News